rawfin.tv
Macquarie Raises ResMed Price Target to A$46.80/Share
MarketsstocksAI Generated

Macquarie Raises ResMed Price Target to A$46.80/Share

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Macquarie has increased its price target for ResMed (RMD) by 0.4%, setting the new target at A$46.80 per share. This adjustment reflects an updated analyst outlook on the medical device company's valuation.

stock-upgradeanalyst-ratingsmedical-devicesAustralia-stocks

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks